Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of HGP1910 and HCP1903 in Primary Hypercholesterolemia
NCT04652349Phase 3Completed
- Sponsor
- Hanmi Pharmaceutical
- Start
- Jul 2020
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of rosuvastatin, ezetimibe in hypercholesterolemia, sponsored by Hanmi Pharmaceutical. Started Jul 2020; status: completed.
02
Drugs
rosuvastatinezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT04652349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04652349.